25736-86-1Relevant articles and documents
Protein-Grafted Polymers Prepared Through a Site-Specific Conjugation by Microbial Transglutaminase for an Immunosorbent Assay
Wakabayashi, Rie,Yahiro, Kensuke,Hayashi, Kounosuke,Goto, Masahiro,Kamiya, Noriho
, p. 422 - 430 (2017)
Protein-polymer conjugates have been developed in many fields. Most hybrids are composed of one protein attached to one or several polymer chains. The other form of hybrid involves the construction of multiple proteins on one polymer chain, thereby facili
Runge-Kutta analysis for optimizing the Zn-catalyzed transesterification conditions of MA and MMA with diols to maximize monoesterified products
Kato, Taito,Akebi, Shin-Ya,Nagae, Haruki,Yonehara, Koji,Oku, Tomoharu,Mashima, Kazushi
, p. 6975 - 6986 (2021/11/17)
Terminal hydroxylated acrylates and methacrylates were prepared by catalytic transesterification of acrylates and methacrylates with diols catalyzed by a system of a tetranuclear zinc alkoxide, [Zn(tmhd)(OMe)(MeOH)]4 (1a), with 4 equiv. of 2,2′-bipyridine (L1). The reaction time to reach the equilibrium state was analyzed by kinetic studies and a curve-fitting analysis based on the Runge-Kutta method for optimizing the best reaction conditions for mono-esterification. In addition to these kinetic analyses, DFT calculations estimated a proposed mechanism of the catalytic transesterification. This journal is
All-cell tumor nano vaccine Preparation method and application thereof
-
Paragraph 0063-0065, (2021/11/21)
The invention relates to a whole-cell tumor nano vaccine and a preparation method and application thereof. The whole-cell tumor nano vaccine is a nano-vaccine of an acid-sensitive polymer-loaded immunoadjuvant, a nano-vaccine of an acid-sensitive polymer - immunologic adjuvant conjugate, a nano vaccine coated with an engineering tumor cell membrane, or a combination of the two. To the whole-cell tumor nano vaccine, dendritic cell antigen presenting efficiency can be enhanced, multiple specific cytotoxic T lymphocytes are activated, efficient anti-tumor recurrence and transfer effects are achieved, and meanwhile, personalized treatment of malignant tumors is facilitated.
Acrylate monomer having hydrophilic end group and a method for preparing the same
-
Paragraph 0093-0106; 0128-0132, (2021/11/02)
More particularly, the present invention relates to an acrylate monomer having a high-purity hydrophilic terminal group which does not contain unreacted 1 water or undesirable by-products, and a method for producing the acrylate monomer. These acrylate monomers are substantially free of polymerization inhibitors. Chemical Formula 1. In Chemical Formula 1, R. 1 Chem. R. 2 Chem. R. 3 May be H, or linear, branched or cyclic C, independently of each other. 1 -C12 alkyl group. R4 Is linear, branched or cyclic C. 1 -C12 alkyl Or C1 -C12 It is alkoxy group, wherein alkyl group carbon atoms can be unsubstituted or substituted with oxygen atoms, n Is an integer selected from 1 and 10.